STOCK TITAN

[Form 4] Absci Corp Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Absci (ABSI) disclosed a Form 4 for a company officer (SVP, CAO). On 10/14/2025, 21,950 shares of common stock were withheld under code “F” to cover tax obligations upon the vesting of restricted stock units. The withholding price was $3.68 per share. After this transaction, the officer directly holds 161,283 shares. The filing states the withholding was for taxes related to RSU vesting and was not a discretionary trade.

Absci (ABSI) ha comunicato una Form 4 per un dirigente aziendale (SVP, CAO). Il 14/10/2025 sono state trattenute 21.950 azioni ordinarie con il codice “F” per coprire gli obblighi fiscali derivanti dalla vesting delle unità azionarie limitate. Il prezzo di trattenuta era $3,68 per azione. Dopo questa operazione, l'officer diretto detiene 161.283 azioni. L'atto di deposito indica che la trattenuta era per tasse relative al vesting delle RSU e non si trattava di una operazione discrezionale.

Absci (ABSI) divulgó un Form 4 para un funcionario de la empresa (SVP, CAO). El 14/10/2025 se retuvieron 21,950 acciones de acciones ordinarias bajo el código “F” para cubrir obligaciones fiscales al vesting de las unidades de acciones restringidas. El precio de retención fue de $3.68 por acción. Después de esta operación, el funcionario posee directamente 161,283 acciones. El formulario indica que la retención fue para impuestos relacionados con el vesting de las RSU y no fue una operación discrecional.

Absci(ABSI)가 회사 임원(SVP, CAO)을 위한 Form 4를 공개했다. 2025년 10월 14일, 제한 주식 단위의 vesting으로 인한 세금 의무를 충당하기 위해 코드 “F”에 따라 21,950주의 보통주가 보류되었다. 보유 가격은 주당 $3.68였다. 이 거래 후 임원은 직접 161,283주의 주식을 보유하게 된다. 서류에 따르면 보류 금액은 RSU vesting과 관련된 세금을 위한 것이며 재량 거래가 아니었다고 명시되어 있다.

Absci (ABSI) a divulgué un Formulaire 4 pour un dirigeant de l’entreprise (SVP, CAO). Le 14/10/2025, 21 950 actions ordinaires ont été retenues sous le code « F » pour couvrir les obligations fiscales lors du vesting des unités d’actions restreintes. Le prix de retenue était de $3,68 par action. Après cette transaction, le dirigeant détient directement 161 283 actions. Le dossier indique que la retenue était destinée aux impôts liés au vesting des RSU et ne s’agissait pas d’une opération discrétionnaire.

Absci (ABSI) legte ein Formular 4 für einen Unternehmensbeamten (SVP, CAO) vor. Am 14.10.2025 wurden 21.950 Aktien Stammaktien unter dem Code „F“ einbehalten, um steuerliche Verpflichtungen im Zusammenhang mit dem Vesting von Restricted Stock Units zu decken. Der Einbehaltpreis betrug $3,68 pro Aktie. Nach dieser Transaktion hält der Beamte direkt 161.283 Aktien. Die Einreichung gibt an, dass der Einbehalt für Steuern im Zusammenhang mit dem RSU-Vesting bestimmt war und kein diskretionärer Handel war.

Absci (ABSI) كشفت عن نموذج 4 لمسؤول في الشركة (SVP, CAO). في 14/10/2025، تم حجز 21,950 سهماً من الأسهم العادية بموجب الرمز “F” لتغطية الالتزامات الضريبية عند vesting وحدات الأسهم المقيدة. كان سعر الحجز $3.68 للسهم الواحد. بعد هذه المعاملة، يملك المسؤول مباشرة 161,283 سهماً. يذكر الملف أن الحجز كان للضرائب المتعلقة بـ RSU vesting وليس تداولاً خاضعاً للاختيار.

Absci (ABSI) 披露了一份公司高管(SVP, CAO)的 Form 4。于 2025-10-14,21,950 股普通股按代码“F”被扣留,用以覆盖限制性股票单位归属时的税务义务。扣留价格为每股 $3.68。此交易后,该高管直接持有 161,283 股。申报文件称,该扣留是为 RSU 归属相关的税费,而非自愿交易。

Positive
  • None.
Negative
  • None.

Absci (ABSI) ha comunicato una Form 4 per un dirigente aziendale (SVP, CAO). Il 14/10/2025 sono state trattenute 21.950 azioni ordinarie con il codice “F” per coprire gli obblighi fiscali derivanti dalla vesting delle unità azionarie limitate. Il prezzo di trattenuta era $3,68 per azione. Dopo questa operazione, l'officer diretto detiene 161.283 azioni. L'atto di deposito indica che la trattenuta era per tasse relative al vesting delle RSU e non si trattava di una operazione discrezionale.

Absci (ABSI) divulgó un Form 4 para un funcionario de la empresa (SVP, CAO). El 14/10/2025 se retuvieron 21,950 acciones de acciones ordinarias bajo el código “F” para cubrir obligaciones fiscales al vesting de las unidades de acciones restringidas. El precio de retención fue de $3.68 por acción. Después de esta operación, el funcionario posee directamente 161,283 acciones. El formulario indica que la retención fue para impuestos relacionados con el vesting de las RSU y no fue una operación discrecional.

Absci(ABSI)가 회사 임원(SVP, CAO)을 위한 Form 4를 공개했다. 2025년 10월 14일, 제한 주식 단위의 vesting으로 인한 세금 의무를 충당하기 위해 코드 “F”에 따라 21,950주의 보통주가 보류되었다. 보유 가격은 주당 $3.68였다. 이 거래 후 임원은 직접 161,283주의 주식을 보유하게 된다. 서류에 따르면 보류 금액은 RSU vesting과 관련된 세금을 위한 것이며 재량 거래가 아니었다고 명시되어 있다.

Absci (ABSI) a divulgué un Formulaire 4 pour un dirigeant de l’entreprise (SVP, CAO). Le 14/10/2025, 21 950 actions ordinaires ont été retenues sous le code « F » pour couvrir les obligations fiscales lors du vesting des unités d’actions restreintes. Le prix de retenue était de $3,68 par action. Après cette transaction, le dirigeant détient directement 161 283 actions. Le dossier indique que la retenue était destinée aux impôts liés au vesting des RSU et ne s’agissait pas d’une opération discrétionnaire.

Absci (ABSI) legte ein Formular 4 für einen Unternehmensbeamten (SVP, CAO) vor. Am 14.10.2025 wurden 21.950 Aktien Stammaktien unter dem Code „F“ einbehalten, um steuerliche Verpflichtungen im Zusammenhang mit dem Vesting von Restricted Stock Units zu decken. Der Einbehaltpreis betrug $3,68 pro Aktie. Nach dieser Transaktion hält der Beamte direkt 161.283 Aktien. Die Einreichung gibt an, dass der Einbehalt für Steuern im Zusammenhang mit dem RSU-Vesting bestimmt war und kein diskretionärer Handel war.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Bedrick Todd

(Last) (First) (Middle)
C/O ABSCI CORPORATION
18105 SE MILL PLAIN BLVD

(Street)
VANCOUVER WA 98683

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Absci Corp [ ABSI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, CAO
3. Date of Earliest Transaction (Month/Day/Year)
10/14/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/14/2025 F 21,950(1) D $3.68 161,283 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Amount reported represents the number of shares withheld by the Issuer to cover the tax withholding obligation in connection with the vesting of these restricted stock units and does not represent a discretionary trade by the reporting person.
Remarks:
/s/ Shelby Walker, attorney-in-fact 10/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Absci (ABSI) report in this Form 4?

An officer (SVP, CAO) had 21,950 shares withheld on 10/14/2025 to satisfy taxes from RSU vesting, coded “F.”

What does transaction code “F” mean on the ABSI Form 4?

Code “F” indicates shares were withheld to pay taxes in connection with equity award vesting.

What price was used for the RSU tax withholding?

The withholding price was $3.68 per share.

How many ABSI shares does the insider hold after the transaction?

Direct beneficial ownership is 161,283 shares following the withholding.

Was this a discretionary sale by the ABSI insider?

No. The filing states the shares were withheld to cover taxes and not a discretionary trade.

What triggered the share withholding at Absci (ABSI)?

The vesting of restricted stock units (RSUs) triggered the tax withholding.
Absci Corp

NASDAQ:ABSI

ABSI Rankings

ABSI Latest News

ABSI Latest SEC Filings

ABSI Stock Data

583.14M
135.37M
9.25%
60.02%
21.14%
Biotechnology
Services-commercial Physical & Biological Research
Link
United States
VANCOUVER